Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors
Erişim
info:eu-repo/semantics/closedAccessTarih
2023Yazar
Saleem, FaizaShamim, Fariha
Özil, Musa
Baltaş, Nimet
Salar, Uzma
Ashraf, Sajda
Ul-Haq, Zaheer
Taha, Muhammad
Solangi, Mehwish
Khan, Khalid Mohammed
Üst veri
Tüm öğe kaydını gösterKünye
Saleem, F., Shamim, F., Özil, M., Baltaş, N., Salar, U., Ashraf, S., Ul-Haq, Z., Taha, M., Solangi, M., & Khan, K. M. (2023). Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors. Future medicinal chemistry, 15(15), 1343–1368. https://doi.org/10.4155/fmc-2023-0073Özet
Background: Researchers seeking new drug candidates to treat diabetes mellitus have been exploring bioactive molecules found in nature, particularly tetrahydropyridines (THPs). Methods: A library of THPs (1–31) were synthesized via a one-pot multicomponent reaction and investigated for their inhibition potential against α-glucosidase and α-amylase enzymes. Results: A nitrophenyl-substituted compound 5 with IC50 values of 0.15 ± 0.01 and 1.10 ± 0.04 μM, and a Km value of 1.30 mg/ml was identified as the most significant α-glucosidase and α-amylase inhibitor, respectively. Kinetic studies revealed the competitive mode of inhibition, and docking studies revealed that compound 5 binds to the enzyme by establishing hydrophobic and hydrophilic interactions and a salt bridge interaction with His279. Conclusion: These molecules may be a potential drug candidate for diabetes in the future.